150 related articles for article (PubMed ID: 4835492)
1. Pharmacoclinical study of oral estramustine phosphate (Estracyt) in advanced carcinoma of the prostate.
Müntzing J; Shukla SK; Chu TM; Mittelman A; Murphy GP
Invest Urol; 1974 Jul; 12(1):65-8. PubMed ID: 4835492
[No Abstract] [Full Text] [Related]
2. [Treatment of prostatic carcinoma with orally administered Estracyt].
Mayer EJ
Ther Umsch; 1975 Feb; 32(2):114-9. PubMed ID: 1118820
[No Abstract] [Full Text] [Related]
3. [Preliminary results of 10 patients with advanced prostatic neoplasm treated with estracyt].
de Leval J; Petit R; Bouffioux C
Acta Urol Belg; 1974 Jul; 42(3):326-35. PubMed ID: 4440596
[No Abstract] [Full Text] [Related]
4. Estracyt in hormone-resistant prostatic carcinoma.
Szendröi Z; Könyves I; Szendi L; Eckhardt S; Hartay F
Int Urol Nephrol; 1974; 6(2):101-10. PubMed ID: 4448622
[No Abstract] [Full Text] [Related]
5. Treatment of rapidly progressing prostatic carcinoma with estracyt.
Lindberg B
J Urol; 1972 Aug; 108(2):303-6. PubMed ID: 5047424
[No Abstract] [Full Text] [Related]
6. Estramustine phosphate therapy in poorly differentiated carcinoma of the prostate.
Edsmyr F; Esposti PL; Andersson L
Scand J Urol Nephrol Suppl; 1980; 55():139-42. PubMed ID: 6938017
[TBL] [Abstract][Full Text] [Related]
7. Recent data on the mechanism of action of oestrogens in the treatment of prostatic tumour patients.
Szendröi Z; Kocsár L; Karika Z; Füzi M; Tarján G; Reischel G; Eckhardt S
Int Urol Nephrol; 1974; 5(3):311-23. PubMed ID: 4829136
[No Abstract] [Full Text] [Related]
8. Continuous versus intermittent oral therapy with estramustine phosphate (Estracyt).
Vahlensieck W; Wegner G
Scand J Urol Nephrol Suppl; 1980; 55():147-9. PubMed ID: 6938018
[TBL] [Abstract][Full Text] [Related]
9. [Serum testosterone and acid phosphatase levels in patients with prostatic cancer treated with Estracyt].
Németh A; Morvay J; Vécsei B
Orv Hetil; 1981 Apr; 122(17):1017-20. PubMed ID: 7022313
[No Abstract] [Full Text] [Related]
10. [Treatment of advanced metastasizing carcinoma of the prostate with estracyt (author's transl)].
Rambausek M; Lutherer S; Terhorst B
Urologe A; 1981 Jul; 20(4):223-7. PubMed ID: 7196632
[TBL] [Abstract][Full Text] [Related]
11. [Cytostatic treatment of prostatic carcinoma. Evaluation study of estramustinphosphate].
Anderes A; Arquint A; Camponovo F; Deppeler O; Doerig R; Heim H; Humbert-Droz P; Jung HP; Magaro L; Sasso M; Vischer C; Wanner J; Wegmann HJ; Ziegler E
Schweiz Rundsch Med Prax; 1971 Sep; 60(38):1276-9. PubMed ID: 5094915
[No Abstract] [Full Text] [Related]
12. Palliative treatment with oral Estracyte in disseminated prostatic carcinoma.
Welvaart K
Arch Chir Neerl; 1975; 27(3):193-8. PubMed ID: 55103
[TBL] [Abstract][Full Text] [Related]
13. Treatment of advanced carcinoma of the prostate with Estracyt.
Nagel R; Kölln CP
Prog Clin Biol Res; 1976; 6():267-84. PubMed ID: 1023214
[No Abstract] [Full Text] [Related]
14. [Treatment with estramustine phosphate in advanced prostatic cancer].
Klein D
Wien Med Wochenschr; 1972 Jul; 122(30):458-60. PubMed ID: 4114990
[No Abstract] [Full Text] [Related]
15. [Treatment of advanced carcinoma of the prostate with estramustine phosphate (estracyt)].
Lancina Martín JA; Chantada Abal V; Lamas Meilan AC; González Martín M
Actas Urol Esp; 1984; 8(5):399-402. PubMed ID: 6524487
[No Abstract] [Full Text] [Related]
16. Proceedings: Cancer of the prostate.
Murphy GP
Cancer; 1973 Nov; 32(5):1089-91. PubMed ID: 4127978
[No Abstract] [Full Text] [Related]
17. [Clinical evaluation of estramustine phosphate in the treatment of patients with advanced breast cancers].
Wada T; Morikawa E; Houjou T; Kadota K; Mori N; Matsunami N; Watatani M; Yasutomi M
Gan To Kagaku Ryoho; 1990 Sep; 17(9):1901-4. PubMed ID: 2393306
[TBL] [Abstract][Full Text] [Related]
18. [Estracyt treatment in prostatic neoplasms].
Sander S
Tidsskr Nor Laegeforen; 1976 Jan; 96(1):27-8. PubMed ID: 1257949
[No Abstract] [Full Text] [Related]
19. Stage D prostatic carcinoma. Survival rate in relapsed patients following new forms of palliation.
Welvaart K; Merrin CE; Mittelman A; Murphy GP
Urology; 1974 Sep; 4(3):283-6. PubMed ID: 4138219
[No Abstract] [Full Text] [Related]
20. [Clinical effects of estramustine phosphate disodium (Estracyt) on prostatic cancer].
Nishio S; Kishimoto T; Maekawa M; Kawakita J; Hayahara N; Yuki K; Morikawa Y; Yasumoto R; Kato Y; Funai K
Hinyokika Kiyo; 1986 Nov; 32(11):1763-70. PubMed ID: 3825823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
